Quantzig Presents a New Portfolio of Advanced Healthcare Analytics Solutions That Focus on Strengthening Drug Pricing & Promotion Strategies

Request a FREE demo for detailed insights

LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems announces the launch of a comprehensive portfolio of advanced healthcare analytics solutions that focus on strengthening the drug pricing and promotion strategies of pharma companies globally.

Request a FREE proposal to learn why analytics needs to be a part of your drug pricing and promotions strategy.

In the ongoing quest to control escalating drug costs, drug pricing transparency has taken center stage in the fight for reform. Transparency advocates believe restructuring the business models would not only expose inequities in the drug pricing pipeline but also create a stronger element of competition that could drive down costs. The goal is to reduce out-of-pocket expenditures for patients by giving them and their physicians access to data with the ultimate goal of making drugs more affordable using advanced healthcare analytics. In a win-win, general healthcare costs would be reduced, as more patients could afford the medications they need, making it less likely their conditions will worsen potentially causing them to be admitted for extended stays.

Quantzig’s healthcare analytics solutions portfolio that focuses on drug promotions and pricing can guide you throughout the journey- right from addressing the institutional challenges of integrating analytics into the pricing approach to developing a promotion strategy that helps drive measurable transformations.

2020 witnessed a rise in drug prices by leading pharma and biopharma companies located across geographies. Wonder how such companies can address the unmet needs of patients without increasing costs? Speak to our analytics experts to learn how advanced healthcare analytics can help.

Quantzig’s comprehensive suite of drug pricing and promotion analytics solutions provide an edge by empowering pharmaceutical companies with advanced analytics solutions that drive results in several ways, including:

1. Informed analysis leads to better medical decisions

Using Quantzig’s advanced healthcare analytics solutions that focus on drug pricing and promotions, healthcare organizations can analyze data and act on insights to drive pricing excellence and share intelligence that will help fuel broader quality improvement and drug development efforts. Request a FREE brochure of our advanced analytics solutions to learn more.

2. Analytical reports on drug pricing trends

Our powerful drug database management models enable pharma companies to make more precise medication-related decisions to improve patient safety and healthcare outcomes. The use of advanced analytical reports that shed light on drug pricing and promotion trends further smoothens the journey of key decision makers. Gain limited-time complimentary access to our analytics platform and learn how we can help you integrate healthcare analytics into operating models.

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal

Contacts

Press Contact
Quantzig
Anirban Choudhury

Marketing Manager

US: +1 630 538 7144

UK: +44 208 629 1455

https://www.quantzig.com/contact-us